Boardroom Alpha
Boardroom Alpha
SMTK · Current Report (Form 8-K) · Filed June 26, 2026

Smartkem Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 26, 2026
Period
Jun 23, 2026
Ticker
SMTK
Accession
0001104659-26-077917
Boardroom Alpha · Filing insights

Stockholders approved multiple governance and capital-structure measures, including authorization increases, reverse-splits framework, and written consent rights.

About Smartkem Inc
Market cap
$2M
1Y TSR
−11.8%
Board grade
D
Sector
Technology
Last annual meeting: Jun 23, 2026 · View full Smartkem Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 23, 2026

 

SmartKem, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 001-42115 85-1083654

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

3 Germay Drive, Unit 4 #1029

Wilmington, DE 19804

(Address of principal executive offices, including zip code)

  

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.0001 per share   SMTK   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b - 2 of the Securities Exchange Act of 1934 (§240.12b - 2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

  

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders

 

On June 23, 2026, SmartKem, Inc., Inc. (the “Company”) held an Annual Meeting of Stockholders (the “Meeting”) to consider and vote on eleven proposals, each of which is described in greater detail in the Company’s definitive proxy statement dated May 18, 2026 and first mailed to stockholders of the Company on or about May 18, 2026 (the “Proxy Statement”). At the close of business on May 11, 2026, the record date for the determination of stockholders entitled to vote at the Meeting, there were 21,446,213 shares of common stock, each share entitled to one vote, constituting all of the outstanding voting securities of the Company. At the Meeting, the holders of 14,391,656 shares of the Company’s common stock were represented in person or by proxy, constituting a quorum. The final voting results for each of the matters submitted to a Company stockholder vote at the Meeting are set forth below. Capitalized terms used and not otherwise defined herein have the meanings given in the Proxy Statement.

 

PROPOSAL ONE: Election of Director Nominees to serve as Class II Directors for a three-year term expiring at the annual meeting of stockholders in 2029;

 

1a. KLAAS DE BOER

 

FOR:   ABSTAIN   BROKER NON-VOTES:
11,511,577   41,600   2,838,479

 

1b. SRIRAM PERUVEMBA

 

FOR:   ABSTAIN   BROKER NON-VOTES:
11,491,588   61,589   2,838,479

 

PROPOSAL TWO: to approve, on an advisory basis, the executive compensation program for the Company’s named executive officers;

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,499,529   49,241   4,407   2,838,479

 

 

 

 

PROPOSAL THREE: to approve, on an advisory basis, the frequency at which future stockholders advisory votes on executive compensation should occur;

 

1 YEAR:   2 YEARS:   3 YEARS   ABSTAIN:
11,498,822   22,095   20,129   12,131

 

·        Broker Non-Votes: 2,838,479

 

PROPOSAL FOUR: to ratify the appointment of CBIZ CPAS P.C. as our independent registered public accounting firm for the year ending December 31, 2026;

 

FOR:   AGAINST:   ABSTAIN
14,281,907   109,055   694

 

PROPOSAL FIVE: to approve an amendment to our Amended and Restated Certificate of Incorporation, to increase the number of shares of Common Stock that the Company is authorized to issue from 300,000,000 to 5,000,000,000 shares;

 

FOR:   AGAINST:   ABSTAIN
13,328,336   1,033,263   30,057

 

PROPOSAL SIX: to approve an amendment to our 2021 Equity Incentive Plan to increase the number of shares of Common Stock that the Company is authorized to issue pursuant to the Plan from 1,643,692 to 2,144,622 shares (prior to giving effect to the Reverse Stock Splits);

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,493,630   58,320   1,227   2,838,479

 

 

 

 

PROPOSAL SEVEN: to approve up to two amendments to our Amended and Restated Certificate of Incorporation to grant discretionary authority to our Board of Directors to effect up to two reverse stock splits;

 

FOR:   AGAINST:   ABSTAIN
14,104,710   244,767   42,179

 

PROPOSAL EIGHT: to approve the issuance of shares of Common Stock below the Nasdaq minimum price in excess of 19.99% of the Company’s issued and outstanding Common Stock in connection with the Company’s Equity Line of Credit;

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,496,232   55,343   1,602   2,838,479

 

PROPOSAL NINE: to approve the issuance of shares of Common Stock below the Nasdaq minimum price in excess of 19.99% of the Company’s issued and outstanding Common Stock in connection with the conversion of the Company’s Series A convertible preferred stock or exercise of related warrants;

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,478,695   72,638   1,844   2,838,479

 

PROPOSAL TEN: to approve an amendment to our Amended and Restated Certificate of Incorporation to permit our stockholders to take action by written consent in lieu of a meeting;

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,494,602   57,405   1,170   2,838,479

 

PROPOSAL ELEVEN: to approve an amendment to our Amended and Restated Certificate of Incorporation to remove the two-thirds supermajority consent requirements for certain matters from our Amended and Restated Certificate of Incorporation;

 

FOR:   AGAINST:   ABSTAIN:   BROKER NON-VOTES:
11,458,369   93,308   1,500   2,838,479

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SMARTKEM, INC.
     
Dated: June 26, 2026 By: /s/ Barbra C. Keck
    Barbra C. Keck
    Chief Financial Officer

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Smartkem Inc (SMTK)

Reference

Frequently asked questions

When did Smartkem Inc file this 8-K?
Smartkem Inc (SMTK) filed this Current Report (Form 8-K) with the SEC on June 26, 2026. The accession number assigned by EDGAR is 0001104659-26-077917.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders approved multiple governance and capital-structure measures, including authorization increases, reverse-splits framework, and written consent rights. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Smartkem Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Smartkem Inc has filed under CIK 1817760, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer